Jeff Calcagno

Corporate Officer/Principal chez VIR BIOTECHNOLOGY, INC.

Profil

Dr. Jeff Calcagno, MD, is a Principal at Johnson & Johnson Development Corp.
Dr. Calcagno began his business career as a management consultant at McKinsey & Company.
He later served as a healthcare research analyst at JP Morgan Hambrecht & Quist.
As an entrepreneur, he ran corporate development and operations for WIDCOMM, a technology company acquired by Broadcom, and served as CFO & CBO for Vela Pharmaceuticals, a venture-backed drug development company.
From 2006 to 2010 he was a Principal & Kauffman Fellow at Scale Venture Partners, a venture fund with over $1B under management.
He has over two decades of healthcare and business experience: as a clinician, management consultant, research analyst, entrepreneur, and venture investor.
Dr. Calcagno graduated Phi Beta Kappa in Biology from Harvard College and earned an MD from Harvard Medical School, where he was a Rotary International Ambassadorial Scholar.

Postes actifs de Jeff Calcagno

Sociétés	Poste	Début
VIR BIOTECHNOLOGY, INC.	Corporate Officer/Principal	15/05/2023

Anciens postes connus de Jeff Calcagno

Sociétés	Poste	Fin
Johnson & Johnson Innovation	Corporate Officer/Principal	01/04/2023
Scale Management LLC	Private Equity Investor	31/05/2011
McKinsey & Co., Inc.	Corporate Officer/Principal	31/12/1990
Johnson & Johnson Innovation - JJDC, Inc.	Private Equity Investor	-
WIDCOMM, Inc.	Corporate Officer/Principal	-

Formation de Jeff Calcagno

Harvard University	Undergraduate Degree
Harvard Medical School	Doctorate Degree